Piramal Pharma Limited (PPLPHARMA) — Working Capital to Net Assets Ratio
Piramal Pharma Limited (PPLPHARMA) has a Working Capital to Net Assets ratio of 29.8% as of March 2026. Working capital of Rs24.33 Billion (current assets of Rs71.92 Billion minus current liabilities of Rs47.58 Billion) is measured against net assets of Rs81.63 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See PPLPHARMA defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Piramal Pharma Limited Working Capital to Net Assets (2021–2026)
This chart shows how Piramal Pharma Limited's Working Capital to Net Assets ratio has evolved across 6 annual periods from 2021 to 2026. As of March 2026, the ratio stands at 29.8%, reflecting working capital of Rs24.33 Billion against net assets of Rs81.63 Billion INR. For the complete balance sheet picture, see PPLPHARMA total assets.
Annual Working Capital to Net Assets for Piramal Pharma Limited (2021–2026)
The table below presents the year-by-year Working Capital to Net Assets ratio for Piramal Pharma Limited from 2021 to 2026, covering 6 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check Piramal Pharma Limited asset resilience ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (INR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2026 | 29.8% | Rs24.33 Billion | Rs81.63 Billion | Rs71.92 Billion | Rs47.58 Billion | ▲ +4.8 pp |
| 2025 | 25.0% | Rs20.31 Billion | Rs81.25 Billion | Rs57.97 Billion | Rs37.66 Billion | ▲ +11.1 pp |
| 2024 | 13.8% | Rs10.95 Billion | Rs79.11 Billion | Rs54.64 Billion | Rs43.69 Billion | ▼ -0.8 pp |
| 2023 | 14.7% | Rs9.92 Billion | Rs67.73 Billion | Rs48.35 Billion | Rs38.43 Billion | ▼ -0.8 pp |
| 2022 | 15.4% | Rs10.34 Billion | Rs66.97 Billion | Rs40.67 Billion | Rs30.33 Billion | ▲ +8.2 pp |
| 2021 | 7.2% | Rs2.96 Billion | Rs41.01 Billion | Rs17.68 Billion | Rs14.72 Billion | — |